Sabra Historical Financial Ratios

SBRA Stock  USD 18.52  0.11  0.60%   
Sabra Healthcare is promptly reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 12.46, Free Cash Flow Yield of 0.0957, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.3 will help investors to properly organize and evaluate Sabra Healthcare REIT financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Sabra Financial Ratios Analysis

Sabra Healthcare REITFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Sabra Healthcare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Sabra financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Sabra Healthcare history.

Sabra Healthcare Financial Ratios Chart

At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 1.53, whereas Dividend Yield is forecasted to decline to 0.07.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Sabra Healthcare REIT stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Sabra Healthcare sales, a figure that is much harder to manipulate than other Sabra Healthcare REIT multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Sabra Healthcare REIT dividend as a percentage of Sabra Healthcare stock price. Sabra Healthcare REIT dividend yield is a measure of Sabra Healthcare stock productivity, which can be interpreted as interest rate earned on an Sabra Healthcare investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Average Inventory

The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.

Payout Ratio

Payout Ratio is the proportion of Sabra Healthcare REIT earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of Sabra Healthcare REIT dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating Sabra Healthcare REIT is paying out more in dividends than it makes in net income.
Most ratios from Sabra Healthcare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Sabra Healthcare REIT current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 1.53, whereas Dividend Yield is forecasted to decline to 0.07.
 2021 2022 2023 2024 (projected)
Dividend Yield0.08860.09650.08410.0653
Price To Sales Ratio5.214.595.0310.02

Sabra Healthcare fundamentals Correlations

0.010.61-0.24-0.41-0.01-0.70.570.610.99-0.05-0.20.14-0.14-0.12-0.12-0.180.590.350.99-0.180.00.480.940.210.03
0.01-0.59-0.320.24-0.06-0.08-0.09-0.590.07-0.140.56-0.080.040.07-0.090.33-0.060.3-0.04-0.2-0.26-0.2-0.13-0.27-0.26
0.61-0.59-0.06-0.670.1-0.320.461.00.580.17-0.720.22-0.06-0.18-0.16-0.350.45-0.140.62-0.080.080.490.70.430.1
-0.24-0.32-0.060.350.220.39-0.05-0.06-0.210.32-0.280.330.38-0.38-0.4-0.08-0.1-0.14-0.190.16-0.350.1-0.140.46-0.37
-0.410.24-0.670.35-0.010.29-0.26-0.67-0.36-0.050.320.230.54-0.23-0.17-0.13-0.290.47-0.340.47-0.2-0.17-0.56-0.05-0.23
-0.01-0.060.10.22-0.010.25-0.70.1-0.040.97-0.31-0.25-0.040.230.240.23-0.71-0.4-0.030.110.08-0.630.21-0.30.06
-0.7-0.08-0.320.390.290.25-0.37-0.32-0.690.40.010.270.39-0.27-0.19-0.14-0.4-0.53-0.740.39-0.2-0.26-0.580.04-0.2
0.57-0.090.46-0.05-0.26-0.7-0.370.460.6-0.61-0.160.520.19-0.48-0.53-0.441.00.40.58-0.09-0.240.970.40.71-0.2
0.61-0.591.0-0.06-0.670.1-0.320.460.580.17-0.720.22-0.06-0.18-0.16-0.350.45-0.140.62-0.080.080.490.70.430.1
0.990.070.58-0.21-0.36-0.04-0.690.60.58-0.06-0.210.2-0.08-0.19-0.21-0.160.620.40.98-0.19-0.090.520.920.26-0.06
-0.05-0.140.170.32-0.050.970.4-0.610.17-0.06-0.37-0.080.060.070.090.13-0.63-0.5-0.070.18-0.01-0.520.21-0.17-0.02
-0.20.56-0.72-0.280.32-0.310.01-0.16-0.72-0.21-0.37-0.21-0.010.230.370.02-0.120.09-0.220.230.26-0.3-0.3-0.480.26
0.14-0.080.220.330.23-0.250.270.520.220.2-0.08-0.210.69-0.98-0.78-0.690.490.110.150.32-0.550.590.070.6-0.53
-0.140.04-0.060.380.54-0.040.390.19-0.06-0.080.06-0.010.69-0.61-0.46-0.710.150.17-0.090.7-0.210.32-0.230.51-0.2
-0.120.07-0.18-0.38-0.230.23-0.27-0.48-0.18-0.190.070.23-0.98-0.610.780.59-0.45-0.08-0.12-0.20.57-0.54-0.06-0.560.55
-0.12-0.09-0.16-0.4-0.170.24-0.19-0.53-0.16-0.210.090.37-0.78-0.460.780.26-0.5-0.3-0.120.060.9-0.61-0.04-0.660.88
-0.180.33-0.35-0.08-0.130.23-0.14-0.44-0.35-0.160.130.02-0.69-0.710.590.26-0.41-0.02-0.21-0.69-0.08-0.49-0.11-0.48-0.11
0.59-0.060.45-0.1-0.29-0.71-0.41.00.450.62-0.63-0.120.490.15-0.45-0.5-0.410.40.59-0.12-0.220.950.420.66-0.18
0.350.3-0.14-0.140.47-0.4-0.530.4-0.140.4-0.50.090.110.17-0.08-0.3-0.020.40.41-0.01-0.270.40.060.13-0.28
0.99-0.040.62-0.19-0.34-0.03-0.740.580.620.98-0.07-0.220.15-0.09-0.12-0.12-0.210.590.41-0.140.020.510.920.250.04
-0.18-0.2-0.080.160.470.110.39-0.09-0.08-0.190.180.230.320.7-0.20.06-0.69-0.12-0.01-0.140.240.0-0.190.130.25
0.0-0.260.08-0.35-0.20.08-0.2-0.240.08-0.09-0.010.26-0.55-0.210.570.9-0.08-0.22-0.270.020.24-0.280.04-0.351.0
0.48-0.20.490.1-0.17-0.63-0.260.970.490.52-0.52-0.30.590.32-0.54-0.61-0.490.950.40.510.0-0.280.320.82-0.25
0.94-0.130.7-0.14-0.560.21-0.580.40.70.920.21-0.30.07-0.23-0.06-0.04-0.110.420.060.92-0.190.040.320.160.06
0.21-0.270.430.46-0.05-0.30.040.710.430.26-0.17-0.480.60.51-0.56-0.66-0.480.660.130.250.13-0.350.820.16-0.33
0.03-0.260.1-0.37-0.230.06-0.2-0.20.1-0.06-0.020.26-0.53-0.20.550.88-0.11-0.18-0.280.040.251.0-0.250.06-0.33
Click cells to compare fundamentals

Sabra Healthcare Account Relationship Matchups

Sabra Healthcare fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio6.045.985.214.595.0310.02
Dividend Yield0.0840.07770.08860.09650.08410.0653
Ptb Ratio1.141.050.880.941.181.53
Days Sales Outstanding117.77133.88307.786.457.4854.61
Book Value Per Share18.6416.5315.4313.2312.1212.46
Free Cash Flow Yield(0.1)0.150.09330.06960.09110.0957
Operating Cash Flow Per Share2.011.991.721.631.371.3
Stock Based Compensation To Revenue0.01480.01320.01390.01190.01210.0115
Pb Ratio1.141.050.880.941.181.53
Ev To Sales9.619.859.228.848.78.26
Free Cash Flow Per Share1.991.211.471.371.30.72
Roic0.05420.04150.0033520.02390.03660.0384
Net Income Per Share0.370.67(0.52)(0.34)0.05950.0565
Payables Turnover1.441.820.991.145.135.38
Sales General And Administrative To Revenue0.0460.05470.06090.06330.07240.11
Cash Per Share4.910.530.250.351.990.26
Pocfratio10.7210.098.329.0910.9817.03
Interest Coverage2.652.40.191.291.942.15
Payout Ratio4.862.01(2.32)(3.57)20.1721.18
Pfcf Ratio10.7214.379.199.0910.9814.53
Days Payables Outstanding253.6200.21369.62319.3171.1967.63
Income Quality5.42.56(3.15)(4.07)21.8522.94
Roe0.01980.0406(0.0335)(0.0254)0.0049080.004663
Pe Ratio57.8925.88(26.19)(36.99)239.84251.83
Return On Tangible Assets0.01160.0234(0.0192)(0.0136)0.0025690.00244
Ev To Free Cash Flow17.0723.6516.2617.518.9824.61
Earnings Yield0.01730.0386(0.0382)(0.027)0.0041690.003961
Intangibles To Total Assets0.01670.01380.0090610.0069820.0057360.00545
Net Debt To E B I T D A4.575.5313.738.215.755.46
Current Ratio2.822.254.574.310.120.11
Tangible Book Value Per Share18.116.1315.1813.0611.9912.22
Receivables Turnover3.12.731.194.226.356.67
Graham Number12.4315.813.410.04.033.83
Shareholders Equity Per Share18.6416.5315.4313.2312.1212.45

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.